此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

术中辐射登记

2026年9月18日 更新者:Albert Einstein College of Medicine

使用 IntraBeam® 系统的术中放射治疗 (IORT) - 注册协议

This registry trial is designed to track the local control rates and side effects of IORT, which will be implemented for women who are suitable partial breast irradiation (PBI) per the latest American Society of Radiation Oncology (ASTRO) guidelines.

研究概览

地位

招聘中

条件

详细说明

Eligible patients will be referred for radiation oncology consultation by the operating surgeon. Patients will be presented with all radiation options and if they choose IORT, they will be offered enrollment onto the registry trial and consented accordingly. The registry will collect treatment data from the operation, radiation and pathology notes post IORT for each patient enrolled. Sources of research material, i.e. resected breast tissue and lymph nodes, will be obtained as part of routine clinical care. No additional tissue will be collected from patients due to enrollment on this registry trial. No additional studies will be performed outside of the routine standard of care.

Post treatment, the registry will collect data based on the standard of care follow up schedule. Follow-up visits will be scheduled 2-3 weeks post-operatively, as per standard of care, to review the final pathology and for the initial toxicity assessment. Patients found to have positive margins and/or lymph node involvement may require further surgery and/or additional external beam radiation. Additional follow-up visits with radiation oncology will be scheduled at 6 months and 1, 2, 3, 4, and 5 years following IORT. Toxicity will be scored using Common Terminology Criteria for Adverse Events (CTCAE) v4.03. Local control will be evaluated using clinical exam and semi-annual to annual mammograms. All such information will be tracked and recorded into the registry database.

研究类型

观察性的

注册 (估计的)

460

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

学习地点

    • New York
      • The Bronx、New York、美国、10467-2490
        • 招聘中
        • Montefiore Medical Center - Moses Campus
        • 接触:
        • 首席研究员:
          • Jana Fox

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

女性

取样方法

非概率样本

研究人群

Patients enrolled on this study will be planned for lumpectomy with or without sentinel node biopsy for early stage breast cancer. Patients will be evaluated by a radiation oncologist who specializes in the treatment of breast cancer and will be deemed to be eligible for IORT. Patients with a history of ipsilateral cancer and/or prior in-field radiation are eligible, as IORT would likely be less toxic than repeat whole or partial breast external beam radiation and can allow patients to avoid mastectomy who wish to do so.

描述

Inclusion Criteria:

  • Female gender
  • Age ≥ 45
  • cT1-2N0, <3.5cm invasive breast cancer, estrogen-receptor positive or DCIS of breast, Grade 1-2, mammographically detected, < 2.5 cm, estrogen-receptor positive
  • Suitable for breast conserving surgery
  • No contraindication to radiation
  • Mammogram within 6 months of planned procedure
  • Fitness for lumpectomy under general anesthesia
  • Planned to receive IORT

Exclusion criteria

  • Known axillary lymph node positive breast cancer (negative biopsy not required)
  • Multicentric cancer in the same breast as diagnosed by clinical examination, mammography, ultrasound, MRI or pathologic assessment, not amenable to excision with negative margins with a single lumpectomy.
  • Patients known to have BRCA 1/2 (breast cancer 1, breast cancer 2) gene
  • Patients undergoing neoadjuvant chemotherapy
  • Pregnancy

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:COHORT
  • 时间观点:PROSPECTIVE

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Number of patients with locally controlled disease
大体时间:5 years following radiation therapy

How many patients have recurrent disease following intra-operative radiation

5 years following radiation therapy
Number of patients with regionally controlled disease
大体时间:5 years following radiation therapy

How many patients have recurrent nodal disease following intra-operative radiation

5 years following radiation therapy
Number of patients with grade 2 or higher toxicities
大体时间:5 years following radiation therapy

How many patients have toxicity as measured by the CTCAE

5 years following radiation therapy

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Jana Fox, MD、Montefiore Medical Center

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2018年8月9日

初级完成 (估计的)

2028年1月1日

研究完成 (估计的)

2032年8月1日

研究注册日期

首次提交

2021年7月29日

首先提交符合 QC 标准的

2021年7月29日

首次发布 (实际的)

2021年8月6日

研究记录更新

最后更新发布 (实际的)

2026年9月22日

上次提交的符合 QC 标准的更新

2026年9月18日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅